“…The rapid decision to perform HTS, short HTS turnaround times, and the efficient interpretation of results were determinant for the management of these latter patients. Among immunocompromised patients, HTS contributed to the detection of viruses for which no assay was performed during conventional work-up: viruses known to cause CNS infections (TBEV, WNV, Cache Valley virus, Saint-Louis encephalitis virus, EBV) [29,30,39,40,42], viruses not known to be responsible for CNS infections (novel HAstV-VA1, HAstV-MLB1, human coronavirus OC43, mumps virus vaccine strain) [23e25, 31,33,41,43,47], and novel viruses (LCMV-related arenavirus) [26]. Focusing on novel HAstV, HTS brought new insights in our understanding of their association with CNS infections [22e24, 31,33,43].…”